Pharmacovigilance & Drug Safety Services Provider in Belarus

Belarus is a strategically important pharmaceutical market within the Eurasian Economic Union (EAEU), offering access to a harmonized regional regulatory system. However, market entry and lifecycle compliance in Belarus require strict adherence to national legislation and EAEU Good Pharmacovigilance Practices (GVP).

Pharmaceutical companies operating in Belarus must establish robust pharmacovigilance systems, ensure local regulatory coordination, and maintain continuous safety monitoring aligned with EAEU standards.

At DDReg, we provide end-to-end pharmacovigilance services in Belarus, helping companies ensure compliance, manage risk, and maintain patient safety across the product lifecycle.

Pharmacovigilance Framework in Belarus

Pharmacovigilance in Belarus is regulated by the Center for Expertise and Testing in Healthcare under the Ministry of Health of the Republic of Belarus.

The authority is responsible for:

  • Monitoring adverse drug reactions (ADRs)
  • Enforcing pharmacovigilance compliance
  • Managing post-marketing surveillance
  • Ensuring public health protection

As part of the EAEU, Belarus follows a harmonized pharmacovigilance framework, requiring alignment with regional standards.

Normative Framework Governing Pharmacovigilance in Belarus

Pharmacovigilance obligations in Belarus are defined through national laws and EAEU regulations:

  • Law on Pharmaceuticals – Establishes the legal framework for pharmaceutical regulation and pharmacovigilance
  • Instruction on the Procedure for Reporting Adverse Reactions to Pharmaceuticals – Defines reporting requirements and timelines for adverse events
  • EAEU Good Pharmacovigilance Practices (GVP) – Harmonized pharmacovigilance framework across EAEU member states

This regulatory structure requires integration of local compliance with regional EAEU pharmacovigilance standards.

Local Pharmacovigilance Requirements in Belarus

Belarus emphasizes local pharmacovigilance accountability combined with regional harmonization.

  • Pharmacovigilance System Requirements
    • MAHs must establish and maintain a pharmacovigilance system
    • Must comply with EAEU GVP requirements
  • Local Contact Person for Pharmacovigilance (LCPPV)
    • Mandatory for all MAHs
    • Must be:
      • Based in Belarus
      • Appropriately qualified and experienced
  • Responsibilities of the LCPPV
    • Management of adverse event (AE) reporting
    • Coordination with regulatory authorities
    • Ensuring compliance with national and EAEU requirements
    • Acting as the primary pharmacovigilance contact within Belarus

This makes local expertise and coordination critical for compliance in Belarus.

Our Pharmacovigilance Services in Belarus

DDReg offers comprehensive drug safety services in Belarus, ensuring compliance with national regulations and EAEU pharmacovigilance standards.

  • + Individual Case Safety Report (ICSR) Management
  • + Aggregate Reporting & Safety Writing
  • + Signal Detection & Risk Management
  • + Local Pharmacovigilance Compliance in Belarus
  • + Literature Screening & Safety Intelligence
  • + Pharmacovigilance Consulting Services in Belarus

Why Choose DDReg as Your Pharmacovigilance Company in Belarus?

EAEU Regulatory Expertise

Deep understanding of Belarus regulations and EAEU pharmacovigilance frameworks.

End-to-End Drug Safety Services

Support across clinical and post-marketing phases.

Compliance-Driven Approach

Ensuring adherence to national laws and regional standards.

Inspection-Ready Systems

Prepared for audits and regulatory inspections.

Scalable & Cost-Effective Solutions

Flexible models for expanding pharmaceutical portfolios.

                          Global Reach Explorer

                          Find Your Solution

                          Progress0 / 3 selected

                          Our Pharmacovigilance (PV) Services Expertise

                          ICSR Case Processing and Submission
                          01

                          ICSR Case Processing and Submission

                          Our advanced Individual Case Safety Report (ICSR) Pharmacovigilance Services are dedicated to ensuring patient safety through precise case handling....

                          Literature Monitoring
                          02

                          Literature Monitoring

                          DDReg’s Literature Monitoring Services offer advanced pharmacovigilance literature screening for drug safety. We help Marketing...

                           Risk Management
                          03

                          Risk Management

                          Our expert risk management solutions ensure patient safety by proactively addressing potential hazards in pharmaceutical...

                          Audit and Compliance
                          04

                          Audit and Compliance

                          Our specialized services ensure that pharmacovigilance systems across the drug development pipeline meet strict regulatory...

                          Pharmacovigilance Signal Management Services
                          05

                          Pharmacovigilance Signal Management Services

                          DDReg’s specialized pharmacovigilance services ensure that potential adverse events are identified and addressed promptly...

                          QPPV Services
                          06

                          QPPV Services

                          DDReg’s expert team provides comprehensive QPPV services designed to strengthen your pharmacovigilance system. We ensure that...

                          Aggregate Safety Reports Services
                          07

                          Aggregate Safety Reports Services

                          DDReg’s comprehensive aggregate safety reports services deliver a detailed benefit‐risk evaluation for pharmaceutical products....

                          Connect with DDReg today to strengthen your pharmacovigilance strategy in Belarus.

                          Frequently Asked
                          Questions

                          01
                          02
                          03
                          04
                          Get in Touch

                          Recommended for You